Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
ClinicalTrials.gov study NCT00490568. IPD Sharing: Not stated. Countries: 29. Publications: 1.
At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19
ClinicalTrials.gov study NCT04656691. IPD Sharing: NO. Countries: 1. Publications: 1.
A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT00287118. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis
ClinicalTrials.gov study NCT03924427. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis
ClinicalTrials.gov study NCT03178669. IPD Sharing: NO. Countries: 10. Publications: 1.
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT02877134. IPD Sharing: Not stated. Countries: 14. Publications: 2.
Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines
ClinicalTrials.gov study NCT03004248. IPD Sharing: NO. Countries: 2. Publications: 2.
Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT01859988. IPD Sharing: Not stated. Countries: 7. Publications: 6.
Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT05061446. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.
ClinicalTrials.gov study NCT04250337. IPD Sharing: YES. Countries: 4. Publications: 1.
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
ClinicalTrials.gov study NCT02136069. IPD Sharing: YES. Countries: 20. Publications: 2.
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT01232569. IPD Sharing: Not stated. Countries: 22. Publications: 1.
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
ClinicalTrials.gov study NCT01381172. IPD Sharing: Not stated. Countries: 3. Publications: 6.
ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT04488419. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
ClinicalTrials.gov study NCT00846365. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03573323. IPD Sharing: YES. Countries: 3. Publications: 4.
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01710046. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
ClinicalTrials.gov study NCT04292730. IPD Sharing: YES. Countries: 15. Publications: 3.
Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
ClinicalTrials.gov study NCT01363011. IPD Sharing: Not stated. Countries: 9. Publications: 2.
Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT02638948. IPD Sharing: Not stated. Countries: 17. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.